Ureidopiperidine Derivatives As Selective Human Nk3 Receptor

Ureidopiperidine Derivatives As Selective Human Nk3 Receptor Antagonists

Abstract: A compound with the formula (I): in which: - R1 and R2 each represent, independently of one another, hydrogen or a (C1-C3)alkyl; - or R1 and R2 together with the nitrogen atom to which they are bound constitute a heterocyclic radical selected from among: a pyrrolidin-1-yl, a piperidin-1-yl, a morpholin-4-yl - or R1 represents a methyl and R2 represents a methoxy; - R3 represents hydrogen or a (C1-C3)alkyl; - as well as its salts with mineral or organic acids and its solvates.

Patent Information

Application #

Filing Date

30 March 2001

Publication Number

40/2005

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

SANOFI-SYNTHELABO

174,AVENUE DE FRANCE, F-75013 PARIS

Inventors

1. ALAIN AULOMBARD

1 RUE DE 1A MANADE, F-34970 LATTES

2. XAVIER EDMONDS-ALT

LA BALAJADE, F-34980 COMBAILLAUX

3. VINCENZO PROIETTO

1 COUR DU MERLE, F-34680 SAINT-GEORGES-D'ORQUES

4. DIDIER VAN BROECK

367 AVENUE DU CHAMP DES MOULINS, F-34570 MURVIEL LES MONTPELLIER

Specification

Documents

Application Documents

#	Name	Date
1	in-pct-2001-00351-mum-wo international publication report (30-3-2001).pdf	2018-08-08
2	IN-PCT-2001-00351-MUM-POWER OF AUTHORITY(19-6-2001).pdf	2018-08-08
3	IN-PCT-2001-00351-MUM-FORM 3(30-3-2001).pdf	2018-08-08
4	IN-PCT-2001-00351-MUM-FORM 19(1-4-2004).pdf	2018-08-08
5	IN-PCT-2001-00351-MUM-FORM 13(6-5-2009).pdf	2018-08-08
6	IN-PCT-2001-00351-MUM-FORM 13(1-8-2002).pdf	2018-08-08
7	IN-PCT-2001-00351-MUM-FORM 1(30-3-2001).pdf	2018-08-08
8	IN-PCT-2001-00351-MUM-DESCRIPTION(COMPLETE)-(30-3-2001).pdf	2018-08-08
9	IN-PCT-2001-00351-MUM-CORRESPONDENCE(IPO)-(27-1-2010).pdf	2018-08-08
10	IN-PCT-2001-00351-MUM-CORRESPONDENCE(6-5-2009).pdf	2018-08-08
11	IN-PCT-2001-00351-MUM-CORRESPONDENCE(1-4-2004).t.pdf	2018-08-08
12	IN-PCT-2001-00351-MUM-CLAIMS(30-3-2001).pdf	2018-08-08